Sign in

CIK 0000811641

  • Non-accelerated filer
  • Smaller reporting company

IMMUCELL CORP /DE/

Sign in to watch
Ticker
ICCC
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
010382980
Phone
+1 207-878-2770
Business address
56 EVERGREEN DR, PORTLAND, ME, 04103
  1. 4 Open-market sale VP & Chief Scientific Officer sold 1,935 shares at an average $6.55 ($12,669)
  2. 4 Open-market sale VP & Chief Scientific Officer sold 2,691 shares at an average $6.58 ($17,711)
  3. 4 Open-market sale Vice President and CSO sold 5,374 shares at an average $6.74 ($36,201)
  4. 4 Returned to the company Director returned 1,009 shares (to the company)
  5. 3/A Insider 3/A
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market buy Director bought 955 shares at $6.67 ($6,370)
  8. 4 Open-market buy Director bought 9,522 shares at $5.25 ($49,991)
  9. 4 Open-market buy Director bought 6,666 shares at $5.25 ($34,997)
  10. 4 Open-market buy Director bought 2,857 shares at $5.25 ($14,999)
  11. 4 Open-market buy Director bought 1,904 shares at $5.25 ($9,996)
  12. 4 Open-market buy Director bought 24,000 shares
  13. 4 Open-market buy Director bought 175 shares at $6.80 ($1,190)
  14. 4 Open-market buy Director bought 3,000 shares at an average $6.63 ($19,881)
  15. 4 Open-market buy Director bought 1,000 shares at $6.73 ($6,730)
  16. 4 Open-market buy Director bought 1,500 shares at $7.27 ($10,905)
  17. 4 Open-market buy Director bought 6,100 shares at an average $7.37 ($44,968)
  18. 5 Insider Annual Insider Trading Report
  19. 4 Open-market buy Director bought 2,100 shares at an average $4.82 ($10,116)
  20. 4 Open-market buy Director bought 400 shares at $4.80 ($1,920)

Page 6 of 13 · 256 filings